Jill Beraud Levi Strauss & CO (LEVI) insider trading activity

Jill Beraud is Director of LEVI STRAUSS & CO. Currently has a direct ownership of 172,446 shares of LEVI, which is worth approximately $2.77 Million. The most recent transaction as insider was on Apr 23, 2025, when has been sold 11,690 shares (Class A Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 172K

231.49% 3M change

232.48% 12M change

Total Value Held $2.77 Million

Jill Beraud Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 23 2025	BUY Grant, award, or other acquisition	-	11,690 Added 6.35%	172,446 Class A Common Stock
Apr 23 2025	BUY Conversion of derivative security	-	108,679 Added 40.34%	160,756 Class A Common Stock
Feb 28 2025	BUY Grant, award, or other acquisition	-	56 Added 0.11%	52,077 Class A Common Stock
Nov 14 2024	BUY Grant, award, or other acquisition	-	60 Added 0.12%	52,021 Class A Common Stock
Aug 20 2024	BUY Grant, award, or other acquisition	-	52 Added 0.1%	51,961 Class A Common Stock
May 23 2024	BUY Grant, award, or other acquisition	-	42 Added 0.08%	51,909 Class A Common Stock
Apr 24 2024	BUY Grant, award, or other acquisition	-	7,642 Added 12.84%	51,867 Class A Common Stock
Feb 23 2024	BUY Grant, award, or other acquisition	-	69 Added 0.16%	44,225 Class A Common Stock
Nov 09 2023	BUY Grant, award, or other acquisition	-	87 Added 0.2%	44,156 Class A Common Stock
Aug 17 2023	BUY Grant, award, or other acquisition	-	88 Added 0.2%	44,069 Class A Common Stock
May 18 2023	BUY Grant, award, or other acquisition	-	129 Added 0.29%	43,981 Class A Common Stock
Apr 19 2023	BUY Grant, award, or other acquisition	-	10,251 Added 18.95%	43,852 Class A Common Stock
Feb 23 2023	BUY Grant, award, or other acquisition	-	168 Added 0.22%	77,962 Class A Common Stock
Nov 21 2022	BUY Grant, award, or other acquisition	-	190 Added 0.24%	77,794 Class A Common Stock
Aug 17 2022	BUY Grant, award, or other acquisition	-	152 Added 0.2%	77,604 Class A Common Stock
May 24 2022	BUY Grant, award, or other acquisition	-	222 Added 0.29%	77,452 Class A Common Stock
Apr 20 2022	BUY Grant, award, or other acquisition	-	7,812 Added 9.19%	77,230 Class A Common Stock
Feb 24 2022	BUY Grant, award, or other acquisition	-	129 Added 0.19%	69,418 Class A Common Stock
Nov 17 2021	BUY Grant, award, or other acquisition	-	81 Added 0.12%	69,289 Class A Common Stock
Aug 18 2021	BUY Grant, award, or other acquisition	-	94 Added 0.14%	69,208 Class A Common Stock
Jul 15 2021	BUY Grant, award, or other acquisition	-	5,455 Added 7.32%	69,114 Class A Common Stock
May 25 2021	BUY Grant, award, or other acquisition	-	72 Added 0.11%	63,659 Class A Common Stock
Feb 26 2021	BUY Grant, award, or other acquisition	-	56 Added 0.09%	63,587 Class A Common Stock

Also insider at

RVNC

Revance Therapeutics, Inc. Healthcare

Jill Beraud

Director

San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LEVI shares.

Notify only if

Value

Insider Trading

Get notified when an Levi Strauss & CO insider buys or sells LEVI shares.

Notify only if

Operation

Value

Type

News

Receive news related to LEVI STRAUSS & CO

Track Activities on LEVI

Account